What Happened
Pentagon Supports Antheia's Bioengineered Yeast Production
The US Department of Defense’s credit office has signed a conditional loan agreement with Antheia Inc. to support the company’s domestic production of key starting materials and active pharmaceutical ingredients using bioengineered yeast. The $80 million investment aims to reduce the nation’s reliance on foreign production and strengthen the essential medicines supply chain in the United States. According to the Pentagon, the vast majority of these materials are currently manufactured outside the US, putting the nation at risk of shortages. The investment was first reported by InsideDefense.com.